FiercePharma2d
Vertex lays out plan to increase access and launch non-opioid pain reliever Journavx
For Vertex these days, it’s all about the launches of three new products—sickle cell disease gene therapy Casgevy, the ...
BioSpace6d
FDA Approval of Vertex’s Non-Opioid Journavx Signals New Era in Pain Treatment
If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for ...
Fox Business13d
Vertex Pharmaceuticals' non-opioid pain medication gets FDA approval
A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug Administration (FDA). The company’s "first-in-class" suzetrigine pain pill ...
The Boston Globe13d
At $31 a day, is Vertex’s new non-addictive painkiller worth the price?
They will if the generic drug is an opioid that carries the potential for addiction and the new medicine is a non-opioid that poses no such known risk. That’s the opinion of top Vertex ...